Allergic Rhinitis and its Impact on Asthma update (ARIA 2008): The perspective from Spain

Journal of Investigational Allergology and Clinical Immunology

Volumn 18, Issue 5, 2008, Pages 327-334

  Mullol, Joaquim ^a,b,h   Valero, A ^a,b,g   Alobid, I ^a,b,g   Bartra, J ^a,b,g   Navarro, A M ^c   Chivato, T ^d   Khaltaev, N ^e   Bousquet, J ^f,g  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Hospital El Tomillar   (Spain)

^d Hospital of the Air   (Spain)

^e Hôpital Arnaud de Villeneuve ^*

^f HÔPITAL ARNAUD DE VILLENEUVE   (France)

^g Hospital Clinic   (Spain)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

Allergic rhinitis; Comorbidities; Epidemiology; Quality of life

Indexed keywords

DECONGESTIVE AGENT; GLUCOCORTICOID; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT;

ALLERGIC RHINITIS; ASTHMA; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; PREVALENCE; PRICK TEST; QUALITY OF LIFE; REVIEW; SKIN TEST; SOCIOECONOMICS; SPAIN; VASOMOTOR RHINITIS;

ANTI-ASTHMATIC AGENTS; ASTHMA; COMORBIDITY; DESENSITIZATION, IMMUNOLOGIC; HEALTH PLANNING GUIDELINES; HUMANS; PREVALENCE; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; SPAIN; TERTIARY PREVENTION;

EID: 55449089855     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Hansel F. Clinical and histopathologic studies of the nose and sinuses in allergy. J Allergy. 1929;1:43-70.
2. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62 (Suppl 85):17-25.
3. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy. 2007;62(12):1359-71.
4. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007;62(Suppl 85):9-16.
5. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007;120(2):381-7.
6. Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy 2007;62(9):1057-63.
7. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy. 2007;62(3):216-23.
8. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global Alliance Against Chronic Respiratory Diseases. World Health Organization. ISBN 978 92 4 156346 8. 2007:148 pages.
9. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H; ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-43.
10. Ait-Khaled N, Odhiambo J, Pearce N, Adjoh KS, Maesano IA, Benhabyles B, Bouhayad Z, Bahati E, Camara L, Catteau C, El Sony A, Esamai FO, Hypolite IE, Melaku K, Musa OA, Ng'ang'a L, Onadeko BO, Saad O, Jerray M, Kayembe JM, Koffi NB, Khaldi F, Kuaban C, Voyi K, M'Boussa J, Sow O, Tidjani O, Zar HJ. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy. 2007;62(3):247-58.
11. Pekkarinen PT, von Hertzen L, Laatikainen T, Makela MJ, Jousilahti P, Kosunen TU, Pantelejev V, Vartiainen E, Haahtela T. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy. 2007;62(3):281-7.
12. Majkowska-Wojciechowska B, Pelka J, Korzon L, Kozlowska A, Kaczala M, Jarzebska M, Gwardys T, Kowalski ML. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy. 2007;62(9):1044-50.
13. Viinanen A, Munhbayarlah S, Zevgee T, Narantsetseg L, Naidansuren T, Koskenvuo M, Helenius H, Terho EO. The protective effect of rural living against atopy in Mongolia. Allergy. 2007;62(3):272-80.
14. van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: linking immunology to accurate phenotype. Allergy. 2007;62(3):237-46.
15. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-334.
16. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593-6.
17. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy. 2005;60(9):1112-5.
18. Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, Lockey RF, Niggemann B, Pawankar R, Price D, Bousquet J. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006;117(5):1054-62.
19. Bonini S, Bonini M, Bousquet J, Brusasco V, Canonica GW, Carlsen KH, Corbetta L, Cummiskey J, Delgado L, Del Giacco SR, Haahtela T, Jaeger S, Moretti C, Palange P, Passalacqua G, Passali D, Pedersen BK, Popov T, Rasi G, Ventura MT, Vignola AM. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy. 2006;61(6):681-92.
20. Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, Baena-Cagnani CE, Bouchard J, Bunnag C, Canonica GW, Carlsen KH, Chen YZ, Cruz AA, Custovic A, Demoly P, Dubakiene R, Durham S, Fokkens W, Howarth P, Kemp J, Kowalski ML, Kvedariene V, Lipworth B, Lockey R, Lund V, Mavale-Manuel S, Meltzer EO, Mullol J, Naclerio R, Nekam K, Ohta K, Papadopoulos N, Passalacqua G, Pawankar R, Popov T, Potter P, Price D, Scadding G, Simons FE, Spicak V, Valovirta E, Wang DY, Yawn B, Yusuf O; GA2LEN. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy. 2006;61(9):1086-96.
21. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol. 2007;119(4):881-91.
22. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, Fokkens W, Kemp J, Ohta K, Price D, Bousquet J; ARIA Initiative Scientific Committee. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy. 2007;62 (Suppl 84):1-41.
23. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758-64.
24. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy. 2003;58(7):672-5.
25. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61(6):693-8.
26. Todo-Bom A, Loureiro C, Almeida MM, Nunes C, Delgado L, Castel-Branco G, Bousquet J. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy. 2007;62(9):1038-43.
27. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol. 2006;118(3):758-9.
28. Valero A, Ferrer M, Sastre J, Navarro AM, Monclus L, Marti-Guadano E, Herdman M, Dávila I, Del Cuvillo A, Colás C, Baró E, Antépara I, Alonso J, Mullol J. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol. 2007;120(2):359-65.
29. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, Bousquet J. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367-72.
30. Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot H, Cohen AF, Diamant Z. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy. 2007;62(4):378-84.
31. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy. 2007;62(9):1091-3.
32. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczy ska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wöhrl S, Dahlén B, Szczeklik A. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy. 2007;62(10):1111-8.
33. Bonini M, Lapucci G, Petrelli G, Todaro A, Pamich T, Rasi G, Bonini S. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy. 2007;62(10):1166-70.
34. Bonini S, Rasi G, Brusasco V, Carlsen KH, Crimi E, Popov T, Schultze-Werninghaus G, Gramiccioni C, Bonini M, Passali D, Bachert C, van Cauwenberge PB, Bresciani M, Bonini S, Calonge M, Montan PG, Serapiao Dos Santos M, Belfort R Jr, Lambiase A, Sacchetti M. Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report. Allergy. 2007;62(6):683-94.
35. Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL, Johns DP, Abramson MJ, Hopper JL, Dharmage SC. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007;120(4):863-9.
36. Chatkin MN, Menezes AM, Victora CG, Barros FC. High prevalence of asthma in preschool children in Southern Brazil: a population-based study. Pediatric Pulmonol. 2003;35(4):296-301.
37. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV, Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV, Radaelli G; Felicita Study Group. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res. 2007;62(2):215-20.
38. Viegi G, La Grutta S. Rhinoconjunctivitis and wheeze in preschool children: a different relationship than in adults (united or coexistent airways disease)? Allergy. 2007;62(4):344-7.
39. Choi SH, Yoo Y, Yu J, Rhee CS, Min YG, Koh YY. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy. 2007;62(9):1051-6.
40. Bateman ED, Jithoo A. Asthma and allergy - a global perspective. Allergy. 2007;62(3):213-5.
41. English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countries. Allergy. 2007;62(3):224-9.
42. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D. ARIA Update. Allergy. 2008;63(Suppl 86):8-160.
43. Schunemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, Stockman L, Wisløff TF, Del Mar C, Hayden F, Uyeki TM, Farrar J, Yazdanpanah Y, Zucker H, Beigel J, Chotpitayasunondh T, Hien TT, Ozbay B, Sugaya N, Oxman AD. Transparent development of the WHO rapid advice guidelines. PLoS Med. 2007 May;4(5):e119.
44. Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, Zuberbier T, Guyatt G, Bousquet J, Schünemann HJ. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy. 2008;63(1):38-46.
45. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, Sitkauskiene B, van Oene C, Faris MA, Ellsworth A, Caldwell MF. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy. 2007;62(9):1078-84.
46. Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, Reiss TF. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin. 2004;20(10):1549-58.
47. Barnes ML, Menzies D, Fardon TC, Burns P, Wilson AM, Lipworth BJ. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy. 2007;62(1):73-80.
48. Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy. 2007;62(8):954-7.
49. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117(4):802-9.
50. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;118(2):434-40.
51. Didier A, Malling HJ, Worm M, Horak F, Jager S, Montagut A, André C, de Beaumont O, Melac M. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;120(6):1338-45.
52. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ, Passalacqua G, Potter P, Valovirta E. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy. 2007;62(3):317-24.
53. Clark J, Schall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy. 2007;62(9):1023-8.
54. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2008;121(1):105-9.
55. Molgaard E, Thomsen SF, Lund T, Pedersen L, Nolte H, Backer V. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy. 2007;62(9):1033-7.
56. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol. 2006;118(5):985-98.
57. Linneberg A, Jorgensen T, Nielsen NH, Madsen F, Frolund L, Dirksen A. The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy. 2000;55(8):767-72.
58. Terreehorst I, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, Bruijnzeel-Koomen CA, Hak E, van Wijk RG. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy. 2002;32(8):1160-5.
59. Georgy V, Fahim HI, El Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur Respir J. 2006;28(4):756-62.
60. Kuyucu S, Saraclar Y, Tuncer A, Geyik PO, Adalioglu G, Akpinarli A, Sekerel BE, Sümbülo lu V. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol. 2006;17(4):269-77.
61. Antonicelli L, Micucci C, Voltolini S, Feliziani V, Senna GE, Di Blasi P, Visonà G, De Marco R, Bonifazi F. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy. 2007;37(6):954-60.
62. Antonicelli L, Micucci C, Voltolini S, Senna GE, Di Blasi P, Visona G, Visonà G, De Marco R, Bonifazi F. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy. 2007;62(9):1064-70.
63. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005;128(5):3140-7.
64. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy. 2007;62(3):310-6.
65. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Host A, Koivikko A, Norberg LA, Valovirta E, Wahn U, Möller C; (The PAT investigator group). Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943-8.
66. Civelek E, Soyer OU, Gemicioglu B, Sekerel BE. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy. 2006;61(12):1454-8.
67. Demoly P, Concas V, Urbinelli R, Allaert F. Evaluation de l'influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enquête ERNANI. Rev Fr Allergol Immunol Clin. 2006;46:626-32.
68. Pereira C, Valero A, Loureiro C, Davila I, Martinez-Cocera, Murio C, Rico P, Palomino R. Iberian study of aeroallergens sensitisation in allergic rhinitis. Allerg Immunol. 2006;38:186-194.
69. Workshop Report, Global Strategy for Asthma Management and Prevention (GINA). Initiative World Health Organization, WHO. Updated November 2006. http://www.ginasthma.com/
70. Alergológica 1995. Factores Epidemiológicos Clínicos y Socioeconómicos de las enfermedades alérgicas en España en 1995. Sociedad Española de Alergología e Inmunología Clínica y Alergia e Inmunología (Eds). Madrid, 1995.
71. Alergológica 2005. Factores Epidemiológicos Clínicos y Socioeconómicos de las enfermedades alérgicas en España en 2005. Sociedad Española de Alergología e Inmunología Clínica y Alergia e Inmunología Clínica. (Eds). Madrid 2005.
72. Navarro A, Valero A, Juliá B, Quirce S. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR Study. J Investig Allergol Clin Immunol. 2008 (In press).
73. Castillo JA; Mullol J. Comorbilidad de rinitis y asma en España. Arch Bronconeumol. 2008 (In press).
74. Valero A, Alonso J, Antépara I, Baró E, Colás C, del Cuvillo A, Ferrer M, Herdman M, Marti-Guadaño E, Monclús L, Mullol J, Navarro-Pulido AM, Navas C, Sastre J and the ESPRINT Group of Investigators. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The ESPRINT Questionnaire. Val Health. 2007;10:466-477.
75. Valero A, Alonso J, Antépara I, Baró E, Colás C, del Cuvillo A, Ferrer M, Herdman M, Marti-Guadaño E, Monclús L, Navarro-Pulido AM, Sastre J, Izquierdo I, Mullol J. Health-related quality of life in allergic rhinitis: comparing the short form ESPRINT-15 and MiniRQLQ questionnaires. Allergy. 2007;62(12):1372-8.
76. Togias A. Mechanistic features of allergic rhinitis. J Allergy Clin Immunol. 2000; 105:S559-604.
77. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21:77-83.
78. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol. 1994; 93(2):413-23.
79. Juniper EF, Howland WC, Roberts NB. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101:163-70.
80. Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy. 2000;30(1):132-40.
81. Thomson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85:338-48.
82. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit. 2005;19(2):135-50.
83. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G; XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004;114:838-44.
84. Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J. 2003;21:116-122.
85. Halpern MT, Schmier JK, Richner R, Guo C, Togias A. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma. 2004;41:117-126.